Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
11/01/2007 | US20070253949 Diagnostics and Therapeutics for Diseases Associated with Plasma Kallikrein (KLKB1) |
11/01/2007 | US20070253933 Carotene Synthase Gene and Uses Therefor |
11/01/2007 | US20070253932 Recombinant adenoviral vectors and methods of use |
11/01/2007 | US20070253904 administering a diabetic patient a formulation containing an aryl hydrocarbon receptor nuclea rtranslocator (ARNT) polypeptide to treat diabetes type I, diabetes type II, impaired glucose tolerance, insulin resistance, and beta cell dysfunction |
11/01/2007 | CA2649820A1 Agent for treating polyglutamine aggregation-caused disease or suppressing onset thereof |
11/01/2007 | CA2646671A1 Methods and compositions for localized secretion of anti-ctla-4 antibodies |
11/01/2007 | CA2639070A1 Novel tumour suppressor |
10/31/2007 | EP1849872A1 Adeno-associated virus vectors and uses thereof |
10/31/2007 | EP1849865A1 RNAi MEDICINE HAVING NO ADVERSE EFFECTS |
10/31/2007 | EP1849802A2 Methods for altering fertility |
10/31/2007 | EP1849799A1 Modified virus capsid protein and the use thereof |
10/31/2007 | EP1849474A1 Antimicrobial peptide and use thereof |
10/31/2007 | EP1848684A1 Ester-linked gemini surfactant compounds for use in gene therapy |
10/31/2007 | EP1848504A2 Wound treatment device for photodynamic therapy and method of using same |
10/31/2007 | EP1680446B1 Compositions comprising melittin-derived peptides and methods for the potentiation of immune responses against target antigens |
10/31/2007 | EP1420801B1 Use of fucans in the treatment of adhesions, arthritis and psoriasis |
10/31/2007 | EP1372691B1 Mucin peptide with immunoenhancing properties |
10/31/2007 | EP1362915B1 Nomuraeae rileyi -origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same |
10/31/2007 | EP1259626B1 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators |
10/31/2007 | EP1192247B9 Sphingosine kinase enzyme |
10/31/2007 | EP1163912B1 Gene therapeutics |
10/31/2007 | EP1078079B1 Methods of forming protein-linked lipidic microparticles, and compositions thereof |
10/31/2007 | EP1064020A4 Methods for diagnosing and treating autoimmune disease |
10/31/2007 | EP0998576B1 Method for producing a recombinant bovine adenovirus vector |
10/31/2007 | EP0871645B1 Modulators of the function of fas/apo1 receptors |
10/31/2007 | CN101065492A Viral vectors |
10/31/2007 | CN101065482A Novel shuttle vector |
10/31/2007 | CN101065400A Genetically engineered cells for therapeutic applications |
10/31/2007 | CN101063160A Sub-clone method for polygene fragment |
10/31/2007 | CN101063151A Equine infectious anaemia virus (EIAV) based retroviral vectors |
10/31/2007 | CN101063142A Human papilloma virus 16 type DNA vaccine and gene adjuvant and its application |
10/31/2007 | CN101063129A Structure and usage of antisense oligonucleotide inhibiting ABHD2 gene expression |
10/31/2007 | CN101062951A Fusion protein exciting immunity generation of body to plague and its coding gene and application |
10/31/2007 | CN101062947A Ciliary neurotrophy factor polypeptide allosteric and application thereof |
10/31/2007 | CN101062417A Method for preparing gene medication carrier by using chitosan modified liposome |
10/31/2007 | CN101062416A Glucan ferroferric oxide magnetic nano-material and the preparing method thereof and the application |
10/31/2007 | CN101062415A Use of IL-18 inhibitors |
10/30/2007 | US7288644 Cellular genes regulated by HIV-1 infection and methods of use thereof |
10/30/2007 | US7288531 Potent inhibition of influenza virus by specifically designed short interfering RNA |
10/30/2007 | US7288521 Growth factor therapy mobilization of stem cells into the peripheral blood |
10/30/2007 | US7288369 Incubating a cell containing an HCV RNA having a heterologous polynucleotide with a sequence encoding a transactivator; the cell has a transactivated coding region with an operator sequence linked to it that encodes a detectable marker; transactivator alters transcription of the coding region |
10/30/2007 | US7288255 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells |
10/30/2007 | US7288251 Antibodies to CD40 |
10/30/2007 | CA2379860C Method for constructing recombinant adenovirus vector |
10/30/2007 | CA2220012C Methods for modulating t cell survival by modulating bcl-xl protein level |
10/25/2007 | WO2007121347A2 Rnai-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions |
10/25/2007 | WO2007121326A2 Compositions and methods for modulating gene expression |
10/25/2007 | WO2007121156A2 Rnai-mediated inhibition of histamine receptor h1-related conditions |
10/25/2007 | WO2007120842A2 Methods and compositions for targeting c-rel |
10/25/2007 | WO2007120613A2 A method and composition for enhancing bone formation |
10/25/2007 | WO2007120557A2 Method and apparatus of low strengh electric field network-mediated delivery |
10/25/2007 | WO2007120479A1 Biodegradable cationic polymers |
10/25/2007 | WO2007120368A2 Immunostimulatory combinations for vaccine adjuvants |
10/25/2007 | WO2007120170A2 Compositions and methods for treating gram positive bacterial infection in a mammalian subject |
10/25/2007 | WO2007119799A1 Marker for detecting myocardial differentiation activity of cell |
10/25/2007 | WO2007119787A1 Phosphatase involved in the regulation of cardiomyocyte differentiation |
10/25/2007 | WO2007119692A1 METHOD OF INHIBITING CANCER CELL PROLIFERATION BY REGULATING eIF4H EXPRESSION |
10/25/2007 | WO2007119623A1 Novel use of g-protein-conjugated receptor and ligand thereof |
10/25/2007 | WO2007119564A1 siRNA SPECIFIC TO WT1 17AA(-)ISOFORM AND USE THEREOF |
10/25/2007 | WO2007119515A1 Novel tumor antigen peptides |
10/25/2007 | WO2007103201A9 Cellular delivery of sirna |
10/25/2007 | WO2007038246A3 Solid polymer delivery compositions and methods for use thereof |
10/25/2007 | WO2006133145A3 Tat-007 and methods of assessing and treating cancer |
10/25/2007 | WO2006105998A3 Treatment of cognitive and learning impairment |
10/25/2007 | WO2006086105A3 Methods and compositions for treating intervertebral disc disorders |
10/25/2007 | WO2006033999A3 Modified adenovirus containing a fiber replacement protein |
10/25/2007 | WO2004094595A3 MODIFIED iRNA AGENTS |
10/25/2007 | WO2002099074A3 Slc7s as modifiers of the p53 pathway and methods of use |
10/25/2007 | WO2001040300A8 Protease resistant tumor suppressor p14(arf) |
10/25/2007 | US20070249554 Methods for therapy of neurodegenerative disease of the brain |
10/25/2007 | US20070249553 Vaccine And Nucleic Acids Capable Of Protecting Poultry Against Colonisation By Campylobacter |
10/25/2007 | US20070249551 Compositions and methods for non-parenteral delivery of oligonucleotides |
10/25/2007 | US20070249550 biodrug delivery a nucleic acid for treating bacterial infection or viral infection; reverse transcriptase enzyme inhibitor; sepsis, septic shock, encephalitis, meningitis, acute respiratory distress syndrome, severe acute respiratory syndrome, tuberculosis, lyme disease, HIV infection |
10/25/2007 | US20070249530 Bcma Polypeptides and Uses Thereof |
10/25/2007 | US20070249061 Screening method of new drug candidates using protein interaction happening after binding a small amount of protein on high sensitive protein chip; can be used for research of protein-protein interactions; peptide composition for treating cancer |
10/25/2007 | US20070249004 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents; exposing a GSK3- beta molecule to a putative inhibitor, and measuring the specific enzymatic activity of said GSK3- beta molecule |
10/25/2007 | US20070248972 Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
10/25/2007 | US20070248659 Individualized cancer therapy |
10/25/2007 | US20070248627 Gene Therapy for Tumors Using Minus-Strand Rna Viral Vectors Encoding Immunostimulatory Cytokines |
10/25/2007 | US20070248626 Recombinant toxin fragments |
10/25/2007 | US20070248614 Vaccination |
10/25/2007 | US20070248599 Treatment of alzheimer's disease with inhibitors of apoe binding to apoe receptor |
10/25/2007 | US20070248593 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods |
10/25/2007 | US20070248589 Spatial for Altering Cell Proliferation |
10/25/2007 | US20070248579 Use of Secreted Protein Products for Preventing and Treating Pancreatic Diseases and/or Obesity and/or Metabolic Syndrome |
10/25/2007 | US20070248578 Mrna Transfected Antigen Presenting Cells |
10/25/2007 | US20070248543 Chicken Deoxycytidine and Deoxyadenosine Kinase Enzymes and Their Use |
10/25/2007 | DE102006018392A1 Therapeutische Zielmoleküle zur Entwicklung neuartiger Medikamente für degenerative Erkrankungen Therapeutic targets for developing novel drugs for degenerative diseases |
10/25/2007 | CA2649114A1 Compositions and methods for modulating gene expression |
10/25/2007 | CA2648386A1 Biodegradable cationic polymers |
10/25/2007 | CA2613453A1 Compositions and methods for treating gram positive bacterial infection in a mammalian subject |
10/24/2007 | EP1847614A1 Compositions for delivering enzymes involved in amino acid metabolism using recombinant adeno-associated virus virions (raav virions), and method and use for treating amino acid metabolic disorders using such raav virions |
10/24/2007 | EP1847607A1 Human p51 protein and antibody |
10/24/2007 | EP1847606A2 Mitogenic regulators |
10/24/2007 | EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
10/24/2007 | EP1846559A1 Tumor-derived biological antigen presenting particles |
10/24/2007 | EP1846107A1 Neuroprotective agents and methods of their use |
10/24/2007 | EP1478784B1 Method and nucleic acids for the analysis of colorectal cell proliferative disorders |
10/24/2007 | CN101060864A Delivery of polynucleotides |
10/24/2007 | CN101060863A Modulation of neuroglia-derived BDNF in the treatment and prevention of pain |